Silicon switches of marketed drugs
- PMID: 17073717
- DOI: 10.2174/138955706778560120
Silicon switches of marketed drugs
Abstract
The application of organosilicon chemistry is a strategy to develop best in class drugs applied to targets that have been validated as tractable and drug-able. Silicon switches of known drugs have been synthesised and evaluated in biological assay systems then compared to their marketed all-carbon counterparts. Recent examples include the silicon switches of drugs haloperidol, fexofenadine, bexarotene and venlafaxine.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources